튜브리스 인슐린 펌프 시장 규모, 점유율, 성장 분석 : 구성요소별, 유통 채널별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Tubeless Insulin Pump Market size was valued at USD 1.42 Billion in 2024 and is poised to grow from USD 1.77 Billion in 2025 to USD 10.28 Billion by 2033, growing at a CAGR of 24.6% during the forecast period (2026-2033).

The global market for tubeless insulin pumps is significantly driven by patient demands for discreet and flexible insulin delivery, paired with technological advancements in automation that enhance glucose management safety and ease. This market encompasses innovative patch-type wearable pumps that administer insulin without tubing, as well as integrated platforms that utilize continuous glucose monitors and mobile applications. The transition from early patch designs to commercially available devices demonstrates rapid industry evolution, with features like wireless connectivity automating basal rate adjustments. Young, active individuals and shift workers increasingly prefer these solutions for their convenience during physical activities or overnight therapy. The affordability of pump devices through reimbursement options encourages healthcare practitioners to prescribe them, highlighting opportunities for strategic partnerships, subscription models, and expansion into emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tubeless Insulin Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tubeless Insulin Pump Market Segments Analysis

Global tubeless insulin pump market is segmented by component, distribution channel, end-user and region. Based on components, the market is segmented into Pod/Pump and Remote/Controller. Based on distribution channels, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. Based on end-user, the market is segmented into Hospitals and Clinics, Home Care Settings and Others. Based on the region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tubeless Insulin Pump Market

One of the key market drivers for the global tubeless insulin pump market is the increasing prevalence of diabetes worldwide. As the number of individuals diagnosed with diabetes continues to rise, there is a growing demand for efficient and convenient insulin delivery systems. Tubeless insulin pumps offer enhanced mobility and flexibility for users, eliminating the inconvenience associated with traditional delivery methods. Furthermore, advancements in technology are leading to the development of more sophisticated, user-friendly, and compact devices, further boosting consumer interest. This combination of increasing diabetes cases and innovative product offerings is propelling significant growth in the market.

Restraints in the Global Tubeless Insulin Pump Market

One key market restraint for the global tubeless insulin pump market is the high cost associated with these advanced devices, which can limit accessibility for patients, particularly in developing regions. The financial burden of acquiring a tubeless insulin pump, along with the ongoing expenses for necessary supplies and maintenance, can dissuade potential users. Additionally, limited insurance coverage for these innovative devices may further inhibit patient adoption. Coupled with the lack of widespread awareness and understanding of their benefits among both healthcare providers and patients, these factors contribute to slower market growth and penetration in various demographics.

Market Trends of the Global Tubeless Insulin Pump Market

The Global Tubeless Insulin Pump market is witnessing a significant trend towards personalized therapy integration, where manufacturers are focusing on enhancing patient care through advanced technology. This involves the seamless incorporation of real-time glucose monitoring, sophisticated algorithms for tailored insulin dosing, and user-centric design elements that cater to individual preferences. Devices are increasingly designed to connect with personal health data and healthcare teams, facilitating customized therapy without disrupting patients' daily routines. Additionally, trends such as modular firmware updates and strategic collaborations with digital firms are accelerating product development and clinical validation, ultimately improving the effectiveness and user experience of insulin delivery systems.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Tubeless Insulin Pump Market Size by Component & CAGR (2026-2033)

• Market Overview
• Pod/Pump
• Remote/Controller

Global Tubeless Insulin Pump Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Tubeless Insulin Pump Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Home Care Settings
• Others

Global Tubeless Insulin Pump Market Size & CAGR (2026-2033)

• North America (Component, Distribution Channel, End-User)
  • US
  • Canada
• Europe (Component, Distribution Channel, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Distribution Channel, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Distribution Channel, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Distribution Channel, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Insulet Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi Apex Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EOFlow
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valeritas
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViCentra
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soylent
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SFC Energy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaSens
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sooil Development
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MannKind Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtrum Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTech Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations